According to RVL Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -C$92.98 M. In 2022 the company made an earning of -C$70.15 M an increase over its 2021 earnings that were of -C$0.11 B.The earnings displayed on this page is the company's Pretax Income.